Navigation Links
Parkinson's Institute research shows that nicotine reduces levodopa-induced dyskinesias
Date:10/24/2007

SUNNYVALE, Calif., October 24, 2007 The Parkinsons Institute and Clinical Center today announced research showing that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent in models of Parkinsons disease. Lead by senior research scientist, Maryka Quik, Ph.D., the research will be published in an upcoming issue of the Annals of Neurology.

Levodopa, the most common drug used to treat Parkinsons disease, is initially very effective. However, long-term treatment often lessens efficacy and causes multiple complications, including abnormal involuntary movements, called dyskinesias. These uncontrolled movements of the head and limbs tend to worsen over time and can become as debilitating as Parkinsons disease itself. Currently, there are only limited therapeutic options for dyskinesias, including reduction in levodopa dose, amantadine administration, and deep brain stimulation for a limited number of patients.

Most of the research on tobacco has focused on its detrimental health effects. Studies conducted over the last 40 years show that the incidence of Parkinsons disease is about 50 percent less in smokers than in the general population. Recent studies in experimental models suggest that the nicotine in smoke may be responsible for this neuroprotective effect. In addition, this is the first research to show that nicotine may also reduce levodopa-induced dyskinesias. With an estimated 1.5 million Parkinsons disease patients in the United States, and levodopa being the top prescribed medication for Parkinsons disease, this study has far-reaching implications for the treatment of Parkinsons disease.

Our hope is that this research represents a useful treatment strategy to reduce the dyskinesias that so many Parkinsons disease patients suffer, said Dr. Maryka Quik of the Parkinsons Institute and Clinical Center in Sunnyvale. Reducing the side effects of levodopa makes it a much more effective and long-term treatment.


'/>"/>

Contact: Alicia Swanson
alicia.swanson@comcast.net
408-836-7170
The Parkinson's Institute
Source:Eurekalert

Related medicine news :

1. Gambling related to Parkinsons medication
2. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
3. Highly Educated More Prone To Parkinsons Disease
4. Make Treatment of Parkinsons More Affordable, Doctors Plead
5. Parkinsons Disease can Be Predicted by Metabolic Pathway
6. Neural Stem Cells Reduce Parkinsons Symptoms in Monkeys
7. Risk of Parkinsons Increased by Exposure to Pesticide and Head Trauma
8. Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms
9. Patients Affected by Parkinsons may Be Benefited from Treadmill Exercise
10. UCLA Researchers Discover Link Between Parkinsons and Narcolepsy
11. First Ever Patch Drug To Treat Parkinsons Symptoms Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... TransWipe Volume 3 is a ... Drag and drop a TransWipe preset between two video clips to instantly add a ... to colored panels with customizable color and orientation options. TransWipe Volume 3 is a ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Einstein Medical ... Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium ... meeting of the American Society of Cataract and Refractive Surgery and the American Society ...
(Date:5/5/2016)... , ... May 05, 2016 , ... This weekend, from Friday, May 6 - Sunday, ... steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in conjunction ... be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... the Wharton Seminars for Business Journalists , led by the Wharton ... business and economic issues.  This one-day program at the Wharton School’s San ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 4, 2016 ... across 154 pages, profiling 09 key companies and ... a professional and in-depth study on the current ... basic overview of the industry including definitions, classifications, ... market analysis is provided for the international market ...
(Date:5/3/2016)... 4, 2016 Research and Markets ... Stem Cell Therapy Market Outlook 2020" report to ... ) , ,Recombinant technology has improved significantly in past ... be developed in coming years. Many cancer drugs have ... cell therapies are also expected to be developed with ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, an ... rheumatic fever, which damaged his heart. He continued enjoying ... by June 2013, Shepherd,s heart was giving out and ... On June 20, 2013, the Mesa, Arizona ... Heart (TAH-t). Like a heart transplant, the SynCardia TAH-t ...
Breaking Medicine Technology: